Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Mylan Inc    

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 10 875 M
EBIT 2016 3 267 M
Net income 2016 2 070 M
Debt 2016 9 941 M
Yield 2016 -
Sales 2017 13 106 M
EBIT 2017 4 206 M
Net income 2017 2 709 M
Debt 2017 9 908 M
Yield 2017 -
P/E ratio 2016 11,91
P/E ratio 2017 9,25
EV / Sales 2016 2,92x
EV / Sales 2017 2,42x
Capitalization 21 789 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through two segments: Generic and Specialty.The Generic pharmaceutical business is conducted primarily in the U.S. and... 
Sector
Pharmaceuticals
Calendar
06/24Shareholder meeting
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
05/26 MYLAN NV : to Present at Goldman Sachs 37th Annual Global Healthcare Conference
05/23 MYLAN NV : Launches First Generic Doryx® Delayed-Release Tablets, 200 mg
05/17 MYLAN NV : Updates Timetable for Commencement of Acceptance Period for Offer for..
05/13 MYLAN NV : to Acquire Renaissance's Leading Topicals-Focused Specialty and Gener..
05/12DJPerrigo Loss Deepens
05/12 MYLAN NV : Launches Generic Frova® Tablets
05/12DJPerrigo Loss Deepens
05/05 MYLAN NV : Launches Generic Apresoline® Injection
05/04 MYLAN NV : to Present at the Bank of America Merrill Lynch 19th Annual Health Ca..
05/03DJU.S. HOT STOCKS : Hot Stocks to Watch
More news
Sector news : Pharmaceuticals - NEC
06:16p JOHNSON & JOHNSON : SIMPONI® Receives CHMP Positive Opinion For Treatment Of Pol..
05:46p JOHNSON & JOHNSON : Remember these? Pinto, Tylenol and other infamous recalls
05:46p GRIFOLS : allocates EUR 213 million to dividends and maintains pay-out at 40% of..
05:45p Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. ..
05:44pDJGLAXOSMITHKLINE : Says European Commission Approves Stem-Cell Therapy
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
2015 Mylan Q4 revenues up 15%, Specialty up 38%
2015 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
2015 Mylan EPS in-line, beats on revenue
2015 Notable earnings after Monday?s close
Advertisement
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Technical analysis trends MYLAN INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions